Author

Philippe de Moerloose

Observed names: De Moerloose P, P DE MOERLOOSE, P De Moerloose, P de Moerloose, de Moerloose, P.

Observed institution: University Hospital of Geneva

OpenAlex ID: A5113764181

Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.

1993 · C Gabay, P Roux-Lombard, et al. · PubMed · 85

Anticardiolipin antibody determination: comparison of three ELISA assays.

1990 · P De Moerloose, G Reber, et al. · PubMed · 19

Oral anticoagulation alone or in combination with aspirin: risks and benefits.

1996 · J Hafner, P de Moerloose, et al. · PubMed · 9

[Bernard-Soulier syndrome in a Swiss family].

1987 · P de Moerloose, J J Vogel, et al. · PubMed · 8

Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.

1990 · M Furlan, C Bögli, et al. · PubMed · 3

Circulating immune complexes in dialyzed patients waiting for renal transplantation.

1981 · G Benzonana, N Carpentier, et al. · PubMed · 3

[For or against preoperative hemostatic evaluation in healthy children?].

1994 · R Favier, P Nguyen, et al. · PubMed · 2

[Dosing of bismuth in blood and urine of patients treated for a short time with insoluble bismuth preparations (author's transl)].

1978 · R Djudzman, E Van den Eeckhout, et al. · PubMed · 2

[New anticoagulants: better knowledge, better prescriptions].

2012 · F Boehlen, P de Moerloose · PubMed · 1

Exclusion of deep vein thrombosis with rapid ELISA D-dimer testing: from theory to daily practice.

1999 · K Hamulyàk, F van der Graaf, et al. · PubMed · 1

[Ambulatory follow-up in oral anticoagulation: recommendations for clinical practice].

1996 · Y Christen, A Perrier, et al. · PubMed · 1

The non-ionic contrast media: thrombosis or haemorrhage?

1989 · C Bernard, B Ody, et al. · PubMed · 1

[Atomic absorption in drug research].

1971 · E van den Eeckhout, P de Moerloose · PubMed · 1

Randomized Study of the Effects of Statin on Inflammatory and Prothrombotic States in Obese Adolescents

2016 · Dirlewanger M, De Moerloose P, et al. · Journal of Paediatrics and Neonatal Disorders

PDF

[Oral anticoagulants and directly observed therapy: the necessity of continuous education].

2014 · Philippe de Moerloose · PubMed

[Thrombotic risk in myeloproliferative neoplasms: what the general practitioner needs to know].

2013 · A Casini, F Boehlen, et al. · PubMed

[Why read the articles in this issue of Angiology and Hemostasis].

2011 · Philippe de Moerloose, Lucia Mazzolai, et al. · PubMed

[Angiography: need for a multidisciplinary approach].

2009 · Lucia Mazzolai, Hayoz Bounameaux, et al. · PubMed

[A reference to know: the 2008 Chest Supplement on antithrombotic agents].

2009 · Philippe de Moerloose, Pierre Fontana, et al. · PubMed

[Two new very promising antithrombotic agents: pentasaccharide and ximelagatran].

2002 · Stefano Regazzoni, Philippe de Moerloose · PubMed

[Thrombopenias induced by heparin: diagnostic and therapeutic innovations].

2001 · M Righini, P de Moerloose · PubMed

[Anticoagulants and platelet antiaggregants: lessons of the last 20 years].

1998 · P De Moerloose, F Boehlen · PubMed

[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems].

1993 · P de Moerloose, D A Tsakiris · PubMed

[Acquired hemophilia. Apropos of a case report with a fatal course].

1988 · P de Moerloose, J D Tissot, et al. · PubMed

[Clinical impact of the standardization of Quick's time].

1988 · P de Moerloose · PubMed

Works count: 33

Citation count: 136

H-index: 4

I10-index: 2